Vpriv (Velaglucerase alfa)

Vpriv (Velaglucerase alfa) is a hydrolytic lysosomal glucocerebroside-specific enzyme used for long-term enzyme replacement therapy (ERT) for patients with type 1 Gaucher disease.

Recommended Dosage: The initial recommended dosage of Vpriv injection for treatment-naïve adults and pediatric patients aged 4 years and older is 60 units per kilogram. This dosage is administered via a 60-minute intravenous infusion every two weeks. Adjustments to the dosage may be made to ensure the patient's therapeutic goals are met and maintained.

• Hypersensitivity reactions, including anaphylaxis, have been reported with Vpriv injections. Monitor patients during infusion for symptoms like rash, hives, or difficulty breathing. Discontinue immediately if severe reactions occur and initiate appropriate medical management.
• There are no adequate studies on Vpriv in pregnant women. Use during pregnancy only if clearly needed, and benefits outweigh potential risks. Healthcare providers should carefully assess risks to the fetus when prescribing to pregnant individuals.
• Limited information exists on the excretion of Vpriv in human breast milk. Caution is advised when prescribing to breastfeeding mothers. Consider the benefits of breastfeeding and potential risks to the infant before initiating treatment.
• The safety and efficacy of Vpriv have been established in pediatric patients aged four years and older. Regular monitoring for adverse effects is essential, as children may have different tolerability and therapeutic responses compared to adults.
• Clinical studies did not include a significant number of elderly patients. Caution is advised when prescribing Vpriv to geriatric patients, considering potential age-related organ function decline and coexisting medical conditions that may affect drug response.

What documents are required to import VPRIV to India?
VPRIV (velaglucerase alfa) for injection can be imported by patients or government hospitals on the name of the patients only.
The following documentation is required to import the product:

• A valid prescription from a qualified doctor.
• Patients diagnostic reports
• Patient ID proof (issued by the government of India)

How does the order be confirmed?
The order will be confirmed only after the receipt of:

• A valid prescription from the Doctor
• Import permit if applicable

Is VPRIV available in India?
VPRIV (velaglucerase alfa injection) is a (prescription drug, prescription medication, or prescription medicine) pharmaceutical drug that legally requires a medical prescription to be dispensed.

IPN (Indian Pharma Network) helps import cancer medicines on the named patient supply (NPS). Indian Pharma Network is the facilitator providing input

• On availability of Vpriv in India (Mumbai, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, Pune etc.)
• On availability in Gulf countries (Bahrain, Oman, Qatar, Kuwait, Iraq, Saudi Arabia, and the UAE).
• Medicine Price.
• Finding Genuine and reliable sources from the USA, Canada, Europe, and Australia
• Ensuring 100% transparency.

VPRIV can be made available to patients, doctors, and hospitals in Mumbai, Goa, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, Srinagar, Jammu, Jaipur, Chandigarh, Ludhiana, Noida, Gurgaon, Lucknow, and Pune and other cities in India. The order will be confirmed only after the receipt of a valid prescription from the doctor and an import permit.

IPN (Indian Pharma Network) can facilitate the supply of VPRIV (prescription medicines) to all locations in the world and India after fulfilling the legal requirement (if applicable).

Please contact +91-9310090915 | Toll-Free Number: 1800-889-1064 or write us at info@indianpharmanetwork.in for Vpriv injection price in India.

We guarantee quality and delivery anywhere in the world as per the buyer’s requirements.

Indian Pharma Network can source the VPRIV (Cancer Treatment Medicines) from across the globe and can supply. Indian Pharma offers its customers worldwide access to the best available treatment.

What is the Generic Name for the trade name drug Vpriv®?

Velaglucerase alfa is a Generic Name for the trade name drug Vpriv®.

What is the Manufacturer's Name of Vpriv®?

Vpriv® is manufactured by Shire plc.

Is Vpriv® approved by the FDA?

Yes, Vpriv® is approved by the FDA. Date of first approval: February 26, 2010.

What is the dosage and form of Vpriv® supplied?

Vpriv® is supplied for injection: 400 units of lyophilized powder single-dose vials for intravenous (IV) use.

What are the most common side effects of Vpriv®?

The most common side effects of Vpriv® are headache, hypersensitivity reactions, dizziness, abdominal pain, joint pain, nausea, back pain, fatigue/asthenia, prolonged activated PTT, and pyrexia.

How much does Vpriv® (Velaglucerase alfa) injection cost in India?

Prices may fluctuate over time due to market dynamics and regulatory changes. To obtain accurate and up-to-date information on Vpriv (Velaglucerase alfa) cost in India, it is recommended that you Call/WhatsApp +91-9310090915 or send mail to info@indianpharmanetwork.in.

Can Vpriv® be available in SAARC countries?

Apart from Gulf countries, Vpriv® can be available in SAARC countries (India, Afghanistan, Maldives, Nepal, Bangladesh, Bhutan, Pakistan, and Sri Lanka). Indian Pharma Network (IPN) can help facilitate the supply of Vpriv® injections in these countries, ensuring access to this therapeutic drug through legal and reliable channels.

Is it safe to buy Vpriv® (Velaglucerase alfa) injections online in India?

Yes, one can buy Vpriv (Velaglucerase alfa) online in India at the lowest price from the Indian Pharma Network (IPN) if this medicinal product is not (yet) registered or available in their country. We can help facilitate the supply of Vpriv® injections through legal channels.

What are the storage conditions of Vpriv® (Velaglucerase alfa) injections?

Store this medicinal product refrigerated at 2°C to 8°C (36°F to 46°F) in the original carton to protect it from light. Do not freeze the medicine.

Indian Pharma Network (IPN) can dispense any valid prescription in the shortest possible time. All prescriptions are dispensed and checked by registered pharmacists and dispatched to the Patient's address only from New Delhi, India.